Consolidation Chemotherapy

DRUG9 trials

Conditions

Acute Myeloid LeukemiaAcute Myeloid Leukemia (AML)ChemoradiotherapyChemotherapyChemotherapy Side EffectsLocally Advanced Rectal CarcinomaLow Anterior Resection SyndromeLung Cancer

Phase 2

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

CompletedNCT02084563

Hospital Israelita Albert EinsteinAcute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative/Myelodysplastic Neoplasm +1

Start: 2012-10-31End: 2016-11-30Updated: 2016-11-08

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

NCT04664504

Jing Jin, M.D.Rectal Cancer

Start: 2020-12-01End: 2025-12-01Target: 150Updated: 2021-06-08

Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

CompletedNCT05274945

Alexandria UniversityRectal Cancer

Start: 2020-01-01End: 2022-01-01Updated: 2022-03-11

Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

CompletedNCT05792735

Shenzhen People's HospitalLocally Advanced Rectal Carcinoma

Start: 2023-04-11End: 2025-01-31Updated: 2025-02-05

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

RecruitingNCT06758830

National Cancer Center Affiliate of Vilnius University Hospital Santaros KlinikosChemoradiotherapy, Chemotherapy, Chemotherapy Side Effects +8

Start: 2025-01-06End: 2029-12-27Target: 400Updated: 2026-05-11

CLEAR-Lung III: Circulating Tumor DNA-Guided Consolidation Chemotherapy and Immunotherapy

Not yet recruitingNCT07858253

Anusha Chidharla, MDLung Cancer

Start: 2026-10-01End: 2030-10-01Target: 43Updated: 2026-10-05

Phase 3

Leukemia Stem Cell Detection in Acute Myeloid Leukemia

TerminatedNCT02927938

Wake Forest University Health SciencesAcute Myeloid Leukemia (AML)

Start: 2016-09-30End: 2018-10-05Updated: 2022-04-21

Phase 4

Total Neoadjuvant Therapy in Rectal Cancer Treatment

NCT04747951

State Scientific Centre of Coloproctology, Russian FederationRectal Cancer

Start: 2020-10-30End: 2023-11-01Target: 280Updated: 2021-02-15

Unknown Phase

Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

RecruitingNCT05496491

Larissa University HospitalRectal Neoplasms

Start: 2022-08-30End: 2029-08-30Target: 84Updated: 2026-08-26

Related Papers

Short-course radiation(SCRT) followed by 6 cycles of cadonilimab plus mFOLFOX6 as neoadjuvant therapy for patients with locally advanced rectal cancer (LARC): A multicenter, single arm, phase II trial (NeoCaCRT).

Journal of Clinical Oncology2025-01-271 citations

Effectiveness of the total neo-adjuvant therapy in rectal cancer treatment. Results of the randomized trial

Koloproktologia2024-02-271 citations

Safety of the total neo-adjuvant therapy in rectal cancer treatment. Preliminary results of the randomized trial

Koloproktologia2022-09-151 citations